Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 691

1.

TORC1 inhibition enhances immune function and reduces infections in the elderly.

Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, Watkins M, Shavlakadze T, Zhou W, Quinn D, Glass DJ, Klickstein LB.

Sci Transl Med. 2018 Jul 11;10(449). pii: eaaq1564. doi: 10.1126/scitranslmed.aaq1564.

PMID:
29997249
2.

Concussion.

Master CL, Mayer AR, Quinn D, Grady MF.

Ann Intern Med. 2018 Jul 3;169(1):ITC1-ITC16. doi: 10.7326/AITC201807030.

PMID:
29971425
3.

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421).

Unger JM, Griffin K, Donaldson GW, Baranowski KM, Good MJ, Reburiano E, Hussain M, Monk PJ, Van Veldhuizen PJ, Carducci MA, Higano CS, Lara PN, Tangen CM, Quinn DI, Wade JL, Iii, Vogelzang NJ, Thompson IM, Jr, Moinpour CM.

J Patient Rep Outcomes. 2018 Jun 13;2:27. doi: 10.1186/s41687-018-0054-5. eCollection 2017.

4.

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association With Overall Survival.

Antonarakis ES, Small EJ, Petrylak D, Quinn DI, Kibel AS, Chang N, Dearstyne E, Harmon M, Campogan D, Haynes H, Vu T, Sheikh NA, Drake CG.

Clin Cancer Res. 2018 Jun 1. pii: clincanres.0638.2018. doi: 10.1158/1078-0432.CCR-18-0638. [Epub ahead of print]

PMID:
29858218
5.

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.

Pal SK, Rosenberg JE, Hoffman-Censits JH, Berger R, Quinn DI, Galsky MD, Wolf J, Dittrich C, Keam B, Delord JP, Schellens JHM, Gravis G, Medioni J, Maroto P, Sriuranpong V, Charoentum C, Burris HA, Grünwald V, Petrylak D, Vaishampayan U, Gez E, De Giorgi U, Lee JL, Voortman J, Gupta S, Sharma S, Mortazavi A, Vaughn DJ, Isaacs R, Parker K, Chen X, Yu K, Porter D, Graus Porta D, Bajorin DF.

Cancer Discov. 2018 Jul;8(7):812-821. doi: 10.1158/2159-8290.CD-18-0229. Epub 2018 May 30.

PMID:
29848605
6.

Low-dimensional dynamical characterization of human performance of cancer patients using motion data.

Hasnain Z, Li M, Dorff T, Quinn D, Ueno NT, Yennu S, Kolatkar A, Shahabi C, Nocera L, Nieva J, Kuhn P, Newton PK.

Clin Biomech (Bristol, Avon). 2018 Jul;56:61-69. doi: 10.1016/j.clinbiomech.2018.05.007. Epub 2018 May 18.

PMID:
29803824
7.

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis.

Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, Harshman LC, Quinn DI, Larkin J, Pal SK, Powles T, Ryan CW, Sternberg CN, Uzzo R, Choueiri TK, Bex A.

Eur Urol. 2018 May 18. pii: S0302-2838(18)30349-X. doi: 10.1016/j.eururo.2018.05.002. [Epub ahead of print] Review.

PMID:
29784193
8.

An eHealth Capabilities Framework for Graduates and Health Professionals: Mixed-Methods Study.

Brunner M, McGregor D, Keep M, Janssen A, Spallek H, Quinn D, Jones A, Tseris E, Yeung W, Togher L, Solman A, Shaw T.

J Med Internet Res. 2018 May 15;20(5):e10229. doi: 10.2196/10229.

9.

Weight Stigma in Men: What, When, and by Whom?

Himmelstein MS, Puhl RM, Quinn DM.

Obesity (Silver Spring). 2018 Jun;26(6):968-976. doi: 10.1002/oby.22162. Epub 2018 Apr 24.

PMID:
29687615
10.

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM.

J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6.

PMID:
29624463
11.

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

Vaughn DJ, Bellmunt J, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Li H, Perini RF, Bajorin DF, de Wit R.

J Clin Oncol. 2018 Jun 1;36(16):1579-1587. doi: 10.1200/JCO.2017.76.9562. Epub 2018 Mar 28.

PMID:
29590008
12.

Vaginal Hysterectomy using the ERBE BiClamp® Bipolar Vessel Sealing System: A Case Series.

Blayney GV, Beirne JP, Hinds L, Quinn D, Dorman GJ.

Ulster Med J. 2017 Sep;86(3):167-171. Epub 2017 Sep 12.

13.

An Examination of Behavioral and Neuronal Effects of Comorbid Traumatic Brain Injury and Alcohol Use.

Mayer AR, Hanlon FM, Claus ED, Dodd AB, Miller B, Mickey J, Quinn DK, Hagerty SL, Seaman B, Hutchison KE.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):294-302. doi: 10.1016/j.bpsc.2017.09.012. Epub 2017 Oct 10.

PMID:
29486871
14.

Active Surveillance for Prostate Cancer: Are We Failing Latino Patients at a Large Safety Net Hospital?

Ballas LK, Kraus R, Ji L, Groshen S, Stern MC, Gill I, Quinn DI, Chung E, Abreu A, Hamilton AS.

Clin Genitourin Cancer. 2018 Feb 6. pii: S1558-7673(18)30077-6. doi: 10.1016/j.clgc.2018.01.018. [Epub ahead of print]

PMID:
29483045
15.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.

PMID:
29420467
16.

Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.

Flanders SC, Kim J, Wilson S, Braziunas J, Greenfield S, Billimek J, Lechpammer S, Lin DW, Karsh L, Quinn DI, Shevrin D, Shore ND, Symanowski JT, Penson DF.

Future Oncol. 2018 Mar;14(6):527-536. doi: 10.2217/fon-2017-0438. Epub 2018 Feb 8.

PMID:
29417827
17.

A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, Frick G, Friedman B, Graßl T, Ichikawa T, Ioannidis JP, Lacy P, McManus R, Murray A, Myers M, Palatini P, Parati G, Quinn D, Sarkis J, Shennan A, Usuda T, Wang J, Wu CO, O'Brien E.

Hypertension. 2018 Mar;71(3):368-374. doi: 10.1161/HYPERTENSIONAHA.117.10237. Epub 2018 Jan 31.

PMID:
29386350
18.

Prolonged Postconcussive Symptoms.

Quinn DK, Mayer AR, Master CL, Fann JR.

Am J Psychiatry. 2018 Feb 1;175(2):103-111. doi: 10.1176/appi.ajp.2017.17020235. No abstract available.

PMID:
29385828
19.

A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, Frick G, Friedman B, Graßl T, Ichikawa T, Ioannidis JP, Lacy P, McManus R, Murray A, Myers M, Palatini P, Parati G, Quinn D, Sarkis J, Shennan A, Usuda T, Wang J, Wu CO, O'Brien E.

J Hypertens. 2018 Mar;36(3):472-478. doi: 10.1097/HJH.0000000000001634.

PMID:
29384983
20.

Spatial requirement for PAMO for transformation of non-native linear substrates.

Carvalho ATP, Dourado DFAR, Skvortsov T, de Abreu M, Ferguson LJ, Quinn DJ, Moody TS, Huang M.

Phys Chem Chem Phys. 2018 Jan 24;20(4):2558-2570. doi: 10.1039/c7cp07172h.

PMID:
29318252
21.

The polarity protein Angiomotin p130 controls dendritic spine maturation.

Wigerius M, Quinn D, Diab A, Clattenburg L, Kolar A, Qi J, Krueger SR, Fawcett JP.

J Cell Biol. 2018 Feb 5;217(2):715-730. doi: 10.1083/jcb.201705184. Epub 2018 Jan 9.

PMID:
29317530
22.

Controlled molecular self-assembly of complex three-dimensional structures in soft materials.

Huang C, Quinn D, Suresh S, Hsia KJ.

Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):70-74. doi: 10.1073/pnas.1717912115. Epub 2017 Dec 18.

23.

Training early childcare providers in evidence-based nutrition strategies can help improve nutrition policies and practices of early childcare centres serving racially and ethnically diverse children from low-income families.

Hollar TL, Cook N, Natale R, Quinn D, Phillips T, DeLucca M.

Public Health Nutr. 2018 May;21(7):1212-1221. doi: 10.1017/S1368980017003573. Epub 2017 Dec 13.

PMID:
29233208
24.

Contrast-enhanced ultrasound of the kidney: a single-institution experience.

Oon SF, Foley RW, Quinn D, Quinlan DM, Gibney RG.

Ir J Med Sci. 2017 Dec 7. doi: 10.1007/s11845-017-1725-6. [Epub ahead of print]

PMID:
29218489
25.

Targeted Electroconvulsive Therapy for Super Refractory Status Epilepticus: A Case Report and Literature Review.

Pinchotti DM, Abbott C, Quinn DK.

Psychosomatics. 2018 May - Jun;59(3):302-305. doi: 10.1016/j.psym.2017.10.004. Epub 2017 Oct 16. No abstract available.

PMID:
29150213
26.

Weight stigma and health: The mediating role of coping responses.

Himmelstein MS, Puhl RM, Quinn DM.

Health Psychol. 2018 Feb;37(2):139-147. doi: 10.1037/hea0000575. Epub 2017 Nov 9.

PMID:
29120192
27.

Adaptive control of turbulence intensity is accelerated by frugal flow sampling.

Quinn DB, van Halder Y, Lentink D.

J R Soc Interface. 2017 Nov;14(136). pii: 20170621. doi: 10.1098/rsif.2017.0621.

PMID:
29118116
28.

A Measure of Emotional Regulation and Irritability in Children and Adolescents: The Clinical Evaluation of Emotional Regulation-9.

Pylypow J, Quinn D, Duncan D, Balbuena L.

J Atten Disord. 2017 Nov 1:1087054717737162. doi: 10.1177/1087054717737162. [Epub ahead of print]

PMID:
29094639
29.

Protein Mass Effects on Formate Dehydrogenase.

Ranasinghe C, Guo Q, Sapienza PJ, Lee AL, Quinn DM, Cheatum CM, Kohen A.

J Am Chem Soc. 2017 Dec 6;139(48):17405-17413. doi: 10.1021/jacs.7b08359. Epub 2017 Nov 27.

PMID:
29083897
30.

Internalizing Weight Stigma: Prevalence and Sociodemographic Considerations in US Adults.

Puhl RM, Himmelstein MS, Quinn DM.

Obesity (Silver Spring). 2018 Jan;26(1):167-175. doi: 10.1002/oby.22029. Epub 2017 Oct 30.

PMID:
29082666
31.

The evolution of chemotherapy for the treatment of prostate cancer.

Quinn DI, Sandler HM, Horvath LG, Goldkorn A, Eastham JA.

Ann Oncol. 2017 Nov 1;28(11):2658-2669. doi: 10.1093/annonc/mdx348. Review.

PMID:
29045523
32.

Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.

Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, Nadel H, Quinn DI, Rohren E, Subramaniam RM, Zukotynski K, Kauffman J, Ahuja S, Griffeth L.

J Nucl Med. 2017 Dec;58(12):2026-2037. doi: 10.2967/jnumed.117.197988. Epub 2017 Oct 12. No abstract available.

PMID:
29025980
33.

Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.

Quinn D, Barnes CN, Yates W, Bourdet DL, Moran EJ, Potgieter P, Nicholls A, Haumann B, Singh D.

Pulm Pharmacol Ther. 2018 Feb;48:71-79. doi: 10.1016/j.pupt.2017.10.003. Epub 2017 Oct 4.

34.

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients.

Loh JM, Tran AL, Ji L, Groshen S, Daneshmand S, Schuckman A, Quinn DI, Dorff TB.

Clin Genitourin Cancer. 2017 Sep 6. pii: S1558-7673(17)30271-9. doi: 10.1016/j.clgc.2017.08.016. [Epub ahead of print]

PMID:
28958673
35.

Catalytic mechanism of phenylacetone monooxygenases for non-native linear substrates.

Carvalho ATP, Dourado DFAR, Skvortsov T, de Abreu M, Ferguson LJ, Quinn DJ, Moody TS, Huang M.

Phys Chem Chem Phys. 2017 Oct 11;19(39):26851-26861. doi: 10.1039/c7cp03640j.

PMID:
28951930
36.

Impact of active concealment of stigmatized identities on physical and psychological quality of life.

Quinn DM, Weisz BM, Lawner EK.

Soc Sci Med. 2017 Nov;192:14-17. doi: 10.1016/j.socscimed.2017.09.024. Epub 2017 Sep 18.

PMID:
28941787
37.

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).

Pili R, Quinn DI, Hammers HJ, Monk P, George S, Dorff TB, Olencki T, Shen L, Orillion A, Lamonica D, Fragomeni RS, Szabo Z, Hutson A, Groman A, Perkins SM, Piekarz R, Carducci MA.

Clin Cancer Res. 2017 Dec 1;23(23):7199-7208. doi: 10.1158/1078-0432.CCR-17-1178. Epub 2017 Sep 22.

PMID:
28939740
38.

Isolation of exosomes from whole blood by integrating acoustics and microfluidics.

Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, Li H, Li P, Quinn D, Dao M, Suresh S, Sadovsky Y, Huang TJ.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10584-10589. doi: 10.1073/pnas.1709210114. Epub 2017 Sep 18.

39.

Why is Aged Acetylcholinesterase So Difficult to Reactivate?

Quinn DM, Topczewski J, Yasapala N, Lodge A.

Molecules. 2017 Sep 4;22(9). pii: E1464. doi: 10.3390/molecules22091464. Review.

40.

Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.

Dorff TB, Longmate JA, Pal SK, Stadler WM, Fishman MN, Vaishampayan UN, Rao A, Pinksi JK, Hu JS, Quinn DI, Lara PN Jr.

Cancer. 2017 Dec 1;123(23):4566-4573. doi: 10.1002/cncr.30942. Epub 2017 Aug 22.

PMID:
28832978
41.

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC).

Gross ME, Dorff TB, Quinn DI, Diaz PM, Castellanos OO, Agus DB.

Clin Genitourin Cancer. 2017 Jul 14. pii: S1558-7673(17)30200-8. doi: 10.1016/j.clgc.2017.07.003. [Epub ahead of print]

PMID:
28826933
42.

Transcranial Direct Current Stimulation to the Right Temporoparietal Junction for Social Functioning in Autism Spectrum Disorder: A Case Report.

Esse Wilson J, Quinn DK, Wilson JK, Garcia CM, Tesche CD.

J ECT. 2018 Mar;34(1):e10-e13. doi: 10.1097/YCT.0000000000000445.

PMID:
28825927
43.

Flavin-dependent thymidylate synthase: N5 of flavin as a Methylene carrier.

Karunaratne K, Luedtke N, Quinn DM, Kohen A.

Arch Biochem Biophys. 2017 Oct 15;632:11-19. doi: 10.1016/j.abb.2017.08.011. Epub 2017 Aug 15. Review.

PMID:
28821425
44.

Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.

Bérard A, Gaedigk A, Sheehy O, Chambers C, Roth M, Bozzo P, Johnson D, Kao K, Lavigne S, Wolfe L, Quinn D, Dieter K, Zhao JP; OTIS (MotherToBaby) Collaborative Research Committee.

Front Pharmacol. 2017 Jul 17;8:402. doi: 10.3389/fphar.2017.00402. eCollection 2017.

45.

Preparing E-Health Ready Graduates: A Qualitative Focus Group Study.

McGregor D, Keep M, Brunner M, Janssen A, Quinn D, Avery J, Togher L, Shaw T.

Stud Health Technol Inform. 2017;239:91-96.

PMID:
28756442
46.

Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.

Yu SS, Ballas LK, Skinner EC, Dorff TB, Sadeghi S, Quinn DI.

Clin Adv Hematol Oncol. 2017 Jul;15(7):543-551. Review.

PMID:
28749918
47.

Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Yu SS, Dorff TB, Ballas LK, Sadeghi S, Skinner EC, Quinn DI.

Clin Adv Hematol Oncol. 2017 Jun;15(6):466-477. Review.

PMID:
28749907
48.

Validation and characterization of a novel method for selective vagal deafferentation of the gut.

Diepenbroek C, Quinn D, Stephens R, Zollinger B, Anderson S, Pan A, de Lartigue G.

Am J Physiol Gastrointest Liver Physiol. 2017 Oct 1;313(4):G342-G352. doi: 10.1152/ajpgi.00095.2017. Epub 2017 Jul 13.

PMID:
28705805
49.

The spectrum of mild traumatic brain injury: A review.

Mayer AR, Quinn DK, Master CL.

Neurology. 2017 Aug 8;89(6):623-632. doi: 10.1212/WNL.0000000000004214. Epub 2017 Jul 12. Review.

PMID:
28701496
50.

A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer.

Yu SS, Athreya K, Liu SV, Schally AV, Tsao-Wei D, Groshen S, Quinn DI, Dorff TB, Xiong S, Engel J, Pinski J.

Clin Genitourin Cancer. 2017 Dec;15(6):742-749. doi: 10.1016/j.clgc.2017.06.002. Epub 2017 Jun 8.

PMID:
28668277

Supplemental Content

Support Center